Durvalumab Market Report

Global and Regional Durvalumab Market Details Research Report 2021-2026

  • POSTDATE：Jun 29, 2021
  • PAGES：196
  • REPORT CODE：GMM746038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Durvalumab Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Durvalumab market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Durvalumab market.

    By Player:

    • Medimmune (AstraZeneca)

    By Type:

    • 24mL Injection

    • 10mL Injection

    By End-User:

    • Locally Advanced Urothelial Carcinoma

    • Metastatic Urothelial Carcinoma

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Durvalumab Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Durvalumab Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Durvalumab Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Durvalumab Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Durvalumab Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Durvalumab Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Medimmune (AstraZeneca)

      • 3.1.1 Medimmune (AstraZeneca) - Company Business Overview

      • 3.1.2 Medimmune (AstraZeneca) - Company Financial Performance

      • 3.1.3 Medimmune (AstraZeneca) - Company Financial Performance of Durvalumab

      • 3.1.4 Durvalumab Product Benchmarking

      • 3.1.5 Strategic Initiatives

    4 Global Durvalumab Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Durvalumab Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of 24mL Injection 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of 10mL Injection 2016-2021

    • 4.3 Global Durvalumab Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of 24mL Injection 2016-2021

      • 4.3.2 Global Sales and Growth Rate of 10mL Injection 2016-2021

    • 4.4 Global Durvalumab Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Durvalumab Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Durvalumab Market Price By Type from 2016 to 2026

    5 Global Durvalumab Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Durvalumab

    • 5.2 Global Durvalumab Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Locally Advanced Urothelial Carcinoma 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Metastatic Urothelial Carcinoma 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Durvalumab Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Locally Advanced Urothelial Carcinoma 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Metastatic Urothelial Carcinoma 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Durvalumab Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Durvalumab Market Sales and Market Share by Application (Forecast)

    6 Global Durvalumab Market Segment Analysis (Geography Level)

    • 6.1 Global Durvalumab Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Durvalumab Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Durvalumab Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Durvalumab Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Durvalumab Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Durvalumab Market from 2016 to 2020

    7. North America Durvalumab Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Durvalumab Market Segment by Countries

      • 7.1.1 North America Durvalumab Market Revenue Segment by Countries

      • 7.1.2 North America Durvalumab Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Durvalumab Market Segment (Product Type Level)

    • 7.3 North America Durvalumab Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Durvalumab Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Durvalumab Market Segment by Countries

      • 8.1.1 Europe Durvalumab Market Revenue Segment by Countries

      • 8.1.2 Europe Durvalumab Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Durvalumab Market Segment (Product Type Level)

    • 8.3 Europe Durvalumab Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Durvalumab Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Durvalumab Market Segment by Countries

      • 9.1.1 Asia Durvalumab Market Revenue Segment by Countries

      • 9.1.2 Asia Durvalumab Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Durvalumab Market Segment (Product Type Level)

    • 9.3 Asia Durvalumab Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Durvalumab Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Durvalumab Market Segment by Countries

      • 10.1.1 South America Durvalumab Market Revenue Segment by Countries

      • 10.1.2 South America Durvalumab Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Durvalumab Market Segment (Product Type Level)

    • 10.3 South America Durvalumab Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Durvalumab Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Durvalumab Market Segment by Countries

      • 11.1.1 Middle East Durvalumab Market Revenue Segment by Countries

      • 11.1.2 Middle East Durvalumab Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Durvalumab Market Segment (Product Type Level)

    • 11.3 Middle East Durvalumab Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Durvalumab Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Durvalumab Market Segment by Countries

      • 12.1.1 Africa Durvalumab Market Revenue Segment by Countries

      • 12.1.2 Africa Durvalumab Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Durvalumab Market Segment (Product Type Level)

    • 12.3 Africa Durvalumab Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Durvalumab Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Durvalumab Market Segment by Countries

      • 13.1.1 Oceania Durvalumab Market Revenue Segment by Countries

      • 13.1.2 Oceania Durvalumab Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Durvalumab Market Segment (Product Type Level)

    • 13.3 Oceania Durvalumab Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Durvalumab Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Durvalumab

      • 14.2.2 Manufacturing Process Analysis of Durvalumab

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Durvalumab Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Durvalumab Industry Market Status, Pre-COVID-19

      • 15.5.3 Durvalumab Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Durvalumab Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Durvalumab Product Picture

    • Table Durvalumab Product Definition

    • Table Study Scope by Types

    • Figure Global Durvalumab Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Durvalumab Market Value by Application (2016 - 2026)

    • Figure Global Durvalumab Market Size and Growth Rate from 2016 to 2026

    • Table Global Durvalumab Production Capacity by Manufacturers (2016-2021)

    • Table Global Durvalumab Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Durvalumab Revenue by Manufacturers (2016-2021)

    • Table Global Durvalumab Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Durvalumab Plant Distribution and Sales Country

    • Table Medimmune (AstraZeneca) - Company Business Overview

    • Figure Medimmune (AstraZeneca) Total Revenue from 2018 to 2020

    • Table Medimmune (AstraZeneca) Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Medimmune (AstraZeneca) Sales and Growth Rate Analysis of Durvalumab

    • Figure Revenue and Market Share Analysis of Medimmune (AstraZeneca)

    • Table Durvalumab Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Durvalumab Market Revenue by Types (Historical)

    • Table Global Durvalumab Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of 24mL Injection 2016-2021

    • Figure Global Revenue and Growth Rate of 10mL Injection 2016-2021

    • Table Global Durvalumab Market Sales by Types (Historical)

    • Table Global Durvalumab Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of 24mL Injection 2016-2021

    • Figure Global Sales and Growth Rate of 10mL Injection 2016-2021

    • Table Global Durvalumab Market Revenue by Types (Forecast)

    • Table Global Durvalumab Market Revenue Market Share by Types (Forecast)

    • Table Global Durvalumab Market Sales by Types (Forecast)

    • Table Global Durvalumab Market Sales Market Share by Types (Forecast)

    • Figure Global Durvalumab Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Durvalumab

    • Table Global Durvalumab Market Revenue by Application (Historical)

    • Table Global Durvalumab Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Locally Advanced Urothelial Carcinoma 2016-2021

    • Figure Global Revenue and Growth Rate of Metastatic Urothelial Carcinoma 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Durvalumab Market Sales by Application (Historical)

    • Table Global Durvalumab Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Locally Advanced Urothelial Carcinoma 2016-2021

    • Figure Global Sales and Growth Rate of Metastatic Urothelial Carcinoma 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Durvalumab Market Revenue by Application (Forecast)

    • Table Global Durvalumab Market Revenue Market Share by Application (Forecast)

    • Table Global Durvalumab Market Sales by Application (Forecast)

    • Table Global Durvalumab Market Sales Market Share by Application (Forecast)

    • Table Global Durvalumab Market Revenue by Geography (Historical)

    • Table Global Durvalumab Market Revenue Market Share by Geography (Historical)

    • Figure Global Durvalumab Revenue Market Share by Geography in 2020

    • Table Global Durvalumab Market Sales by Geography (Historical)

    • Table Global Durvalumab Market Sales Market Share by Geography (Historical)

    • Figure Global Durvalumab Sales Market Share by Geography in 2020

    • Table Global Durvalumab Market Revenue by Geography (Forecast)

    • Table Global Durvalumab Market Revenue Market Share by Geography (Forecast)

    • Table Global Durvalumab Market Sales by Geography (Forecast)

    • Table Global Durvalumab Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Durvalumab Revenue by Countries from 2016 to 2026

    • Table North America Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Durvalumab Revenue Market Share by Major Countries in 2020

    • Table North America Durvalumab Sales by Countries from 2016 to 2026

    • Table North America Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure North America Durvalumab Sales Market Share by Major Countries in 2020

    • Figure USA Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure USA Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table North America Durvalumab Sales by Types from 2016 to 2026

    • Table North America Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table North America Durvalumab Value by Types from 2016 to 2026

    • Table North America Durvalumab Value Market Share by Types from 2016 to 2026

    • Table North America Durvalumab Sales by Application from 2016 to 2026

    • Table North America Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table North America Durvalumab Value by Application from 2016 to 2026

    • Table North America Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Europe Durvalumab Revenue by Countries from 2016 to 2026

    • Table Europe Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Durvalumab Revenue Market Share by Major Countries in 2020

    • Table Europe Durvalumab Sales by Countries from 2016 to 2026

    • Table Europe Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Durvalumab Sales Market Share by Major Countries in 2020

    • Figure Germany Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure France Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure France Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Durvalumab Sales by Types from 2016 to 2026

    • Table Europe Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table Europe Durvalumab Value by Types from 2016 to 2026

    • Table Europe Durvalumab Value Market Share by Types from 2016 to 2026

    • Table Europe Durvalumab Sales by Application from 2016 to 2026

    • Table Europe Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table Europe Durvalumab Value by Application from 2016 to 2026

    • Table Europe Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Asia Durvalumab Revenue by Countries from 2016 to 2026

    • Table Asia Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Durvalumab Revenue Market Share by Major Countries in 2020

    • Table Asia Durvalumab Sales by Countries from 2016 to 2026

    • Table Asia Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Durvalumab Sales Market Share by Major Countries in 2020

    • Figure China Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure China Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure India Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure India Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Durvalumab Sales by Types from 2016 to 2026

    • Table Asia Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table Asia Durvalumab Value by Types from 2016 to 2026

    • Table Asia Durvalumab Value Market Share by Types from 2016 to 2026

    • Table Asia Durvalumab Sales by Application from 2016 to 2026

    • Table Asia Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table Asia Durvalumab Value by Application from 2016 to 2026

    • Table Asia Durvalumab Value Market Share by Application from 2016 to 2026

    • Table South America Durvalumab Revenue by Countries from 2016 to 2026

    • Table South America Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Durvalumab Revenue Market Share by Major Countries in 2020

    • Table South America Durvalumab Sales by Countries from 2016 to 2026

    • Table South America Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure South America Durvalumab Sales Market Share by Major Countries in 2020

    • Figure Brazil Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table South America Durvalumab Sales by Types from 2016 to 2026

    • Table South America Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table South America Durvalumab Value by Types from 2016 to 2026

    • Table South America Durvalumab Value Market Share by Types from 2016 to 2026

    • Table South America Durvalumab Sales by Application from 2016 to 2026

    • Table South America Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table South America Durvalumab Value by Application from 2016 to 2026

    • Table South America Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Middle East Durvalumab Revenue by Countries from 2016 to 2026

    • Table Middle East Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Durvalumab Revenue Market Share by Major Countries in 2020

    • Table Middle East Durvalumab Sales by Countries from 2016 to 2026

    • Table Middle East Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Durvalumab Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Durvalumab Sales by Types from 2016 to 2026

    • Table Middle East Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table Middle East Durvalumab Value by Types from 2016 to 2026

    • Table Middle East Durvalumab Value Market Share by Types from 2016 to 2026

    • Table Middle East Durvalumab Sales by Application from 2016 to 2026

    • Table Middle East Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table Middle East Durvalumab Value by Application from 2016 to 2026

    • Table Middle East Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Africa Durvalumab Revenue by Countries from 2016 to 2026

    • Table Africa Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Durvalumab Revenue Market Share by Major Countries in 2020

    • Table Africa Durvalumab Sales by Countries from 2016 to 2026

    • Table Africa Durvalumab Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Durvalumab Sales Market Share by Major Countries in 2020

    • Figure Nigeria Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Durvalumab Sales by Types from 2016 to 2026

    • Table Africa Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table Africa Durvalumab Value by Types from 2016 to 2026

    • Table Africa Durvalumab Value Market Share by Types from 2016 to 2026

    • Table Africa Durvalumab Sales by Application from 2016 to 2026

    • Table Africa Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table Africa Durvalumab Value by Application from 2016 to 2026

    • Table Africa Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Oceania Durvalumab Revenue by Countries from 2016 to 2026

    • Table Oceania Durvalumab Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Durvalumab Revenue Market Share by Major Countries in 2020

    • Table Oceania Durvalumab Sales by Countries from 2016 to 2026

    • Table Oceania Durvalumab Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Durvalumab Sales Market Share by Major Countries in 2020

    • Figure Australia Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Value and Growth Rate from 2016 to 2026

    • Figure Others Durvalumab Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Durvalumab Sales by Types from 2016 to 2026

    • Table Oceania Durvalumab Sales Market Share by Types from 2016 to 2026

    • Table Oceania Durvalumab Value by Types from 2016 to 2026

    • Table Oceania Durvalumab Value Market Share by Types from 2016 to 2026

    • Table Oceania Durvalumab Sales by Application from 2016 to 2026

    • Table Oceania Durvalumab Sales Market Share by Application from 2016 to 2026

    • Table Oceania Durvalumab Value by Application from 2016 to 2026

    • Table Oceania Durvalumab Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Durvalumab

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Durvalumab with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US